Innospec reported a strong fourth quarter with a 24% increase in revenue to $510.7 million and net income of $25.5 million. Adjusted non-GAAP EPS was $1.20. The company highlighted strong operating income growth and margin improvement.
Total revenues increased by 24% to $510.7 million compared to the previous year.
Net income was $25.5 million, or $1.02 per diluted share.
Adjusted non-GAAP EPS was $1.20 per diluted share.
Cash from operating activities was $78.4 million before capital expenditures.
Innospec anticipates technology-based organic growth opportunities across all businesses and expects to complete their $70 million Performance Chemicals expansion while continuing dividend growth and share repurchases.
Visualization of income flow from segment revenue to net income